Compositions and methods for evaluating genomic alterations
US-12584163-B2 · Mar 24, 2026 · US
This page is not indexed by search engines while we improve data quality.
Fabrizio David patents
Fabrizio David is listed as an inventor on 54 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Fabrizio David |
| Total patents | 54 |
| First publication | Mar 3, 2015 |
| Latest publication | Mar 24, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Characterization of tumor heterogeneity as a prognostic biomarker
US-2026058014-A1 · Feb 26, 2026 · US
Serum albumin-binding fibronectin type III domains
US-12534511-B2 · Jan 27, 2026 · US
Compositions and methods for evaluating genomic alterations
US-12473589-B2 · Nov 18, 2025 · US
Therapeutic and diagnostic methods for cancer
US-2025306027-A1 · Oct 2, 2025 · US
Therapeutic and diagnostic methods for cancer
US-2025244329-A1 · Jul 31, 2025 · US
Methods and systems for determining tumor heterogeneity
US-2025210194-A1 · Jun 26, 2025 · US
Therapeutic and diagnostic methods for cancer
US-12331128-B2 · Jun 17, 2025 · US
Compositions and methods for evaluating genomic alterations
US-2025171836-A1 · May 29, 2025 · US
PD-L1 binding polypeptides for imaging
US-12194110-B2 · Jan 14, 2025 · US
Recent patents
Latest publications not already listed above.
Methods of treating cancer
US-2024392378-A1 · Nov 28, 2024 · US
Therapeutic and diagnostic methods for cancer
US-2024288430-A1 · Aug 29, 2024 · US
Methods of treating cancer
US-11725247-B2 · Aug 15, 2023 · US
Therapeutic and diagnostic methods for cancer
US-11674962-B2 · Jun 13, 2023 · US
Therapeutic and diagnostic methods for cancer
US-2022412981-A1 · Dec 29, 2022 · US
Pet imaging with pd-l1 binding polypeptides
US-2022347324-A1 · Nov 3, 2022 · US
Serum albumin-binding fibronectin type iii domains
US-2022204589-A1 · Jun 30, 2022 · US
PET imaging with PD-L1 binding polypeptides
US-11344639-B2 · May 31, 2022 · US
Therapeutic and diagnostic methods for cancer
US-2022153861-A1 · May 19, 2022 · US
Therapeutic and diagnostic methods for cancer
US-11300570-B2 · Apr 12, 2022 · US
Therapeutic and diagnostic methods for cancer
US-11279767-B2 · Mar 22, 2022 · US
Novel pd-l1 binding polypeptides for imaging
US-2022001040-A1 · Jan 6, 2022 · US
Serum albumin-binding fibronectin type III domains
US-11203630-B2 · Dec 21, 2021 · US
PD-L1 binding polypeptides for imaging
US-11173219-B2 · Nov 16, 2021 · US
Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR
US-11149077-B2 · Oct 19, 2021 · US
Serum albumin binding molecules
US-10934572-B2 · Mar 2, 2021 · US
Targeted therapeutics based on engineered proteins that bind egfr
US-2021040181-A1 · Feb 11, 2021 · US
Targeted therapeutics based on engineered proteins that bind EGFR
US-10781247-B2 · Sep 22, 2020 · US
Compositions and methods for evaluating genomic alterations
US-2020149097-A1 · May 14, 2020 · US
Serum albumin-binding fibronectin type iii domains
US-2020048328-A1 · Feb 13, 2020 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Bristol Myers Squibb Co | 33 |
| Found Medicine Inc | 21 |
| Genentech Inc | 13 |
| Univ Vanderbilt | 2 |
| Gosselin Michael L | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K14/78 | 30 |
| A61P35/00 | 25 |
| C12Q2600/156 | 20 |
| A61K38/00 | 19 |
| A61K2039/505 | 19 |